TELESTA THERAPEUTICS INC T.TST

BNC's G&M Article....

[rgonlyfactspls]

"A" for effort re: descriptive overview & outline of strategy.
"F" for compelling "case for/ strengths" of Urocidin.

At least new management will have more tries at above.
Just get it right much sooner-than-later (i.e., next time)!

Nevertheless, appreciate BNC Management's focus & effort
that achieved today's outcome and opportunities for tomoro. rg

[Nohandledzep]

RG... With all due respect to some of the measures that the new management have taken, I don't think that they feel compelled in any way, shape or form to make a compelling argument for Urocidin. The message as I see it is that Urocidin was the least bad of 3 bad options so that is what they are running with. Clearly, no one cares. As simple as the voting procedure was, a 40% turn out

[Pogo3]

I find it hard to beleive that after having arranging a meeting in Toronto, and with all the concerns regarding the vote and it’s outcome, the meeting consisted of a 5 minute vote, with no other business or messaging to the shareholders or the business community, no wonder the SP and the company’s reputation remains in doubt. W.T.F.